San Francisco, California 94107


The goal of this study is to visualize biodistribution of a PET tracer called [18F]F-AraG through time in healthy human volunteers.

Study summary:

A positron emission tomography (PET) imaging tracer will be intravenously injected into healthy human volunteers who provide informed consent. Following injection of this tracer each volunteer will have four whole-body PET scans inside a PET scanner to obtain images of tracer biodistribution at four different time points. This will allow studying the kinetics of the tracer as well analysis of tracer dosimetry. Safety of the tracer will also be analyzed in each volunteer.


Inclusion Criteria: - Healthy human subjects without history of chronic disease or at present an acute disease will be included. - Ability to abide by the study conditions is also a requirement for inclusion. Exclusion Criteria: - Individuals under the age of 18 years and pregnant women will be excluded from the [18F]F-AraG imaging studies. - Women who are breast-feeding will be excluded from the study. - Individuals unable to provide informed consent will be excluded.



Primary Contact:

Principal Investigator
Henry VanBrocklin, Ph.D.
University of California, San Francisco

Henry VanBrocklin, Ph.D.
Phone: 415-353-4569

Backup Contact:

Samuel Quezada, MBA
Phone: 650-799-1589

Location Contact:

San Francisco, California 94107
United States

Kenneth Gao
Phone: 415-353-9437

Site Status: Recruiting

Data Source:

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.